Authentikos Wealth Advisory, LLC Bristol Myers Squibb CO Transaction History

Authentikos Wealth Advisory, LLC

  • $104 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$47.98 - $54.4 $1,487 - $1,686
31 Added 0.7%
4,431 $240 Million
Q3 2023

Nov 06, 2023
SELL
$57.89 - $64.73 $405 - $453
-7 Reduced 0.16%
4,400 $255 Million
Q1 2023

Apr 04, 2023
BUY
$65.71 - $74.53 $289,583 - $328,453
4,407 New
4,407 $317 Million

Others Institutions Holding BMY

# of Institutions
2,453
Shares Held
1.5B
Call Options Held
29.6M
Put Options Held
32.1M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Authentikos Wealth Advisory, LLC Portfolio

Follow Authentikos Wealth Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Authentikos Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Authentikos Wealth Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email